D-Ornithine

D-Ornithine

SCHEMBL43724

NCCC[C@@H](N)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ornithine SCHEMBL30563013 1.00 — —
D-Ornithine SCHEMBL1537220 1.00 GSR (0.86) —
Ornithine SCHEMBL30695803 1.00 — —
Ornithine SCHEMBL624782 1.00 GSR (0.86) —
Ornithine SCHEMBL20362354 1.00 — —
Ornithine Aketoglutarate SCHEMBL8578 1.00 — —
Ornithine SCHEMBL30695804 1.00 — —
Ornithine Aketoglutarate SCHEMBL1326163 1.00 GSR (0.86) —
Ornithine Aketoglutarate SCHEMBL42530 1.00 GSR (0.86) —
Ornithine SCHEMBL8579 1.00 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5928 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 — — EP claimed
CN-122074077-A Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy 省卫生服务机构 2026-05-22 — — CN claimed
CN-122070294-A Stable vitreous material based on histidine, arginine and glutamic acid amino acids 阵序补丁有限公司 2026-05-19 — — CN claimed
WO-2026100725-A1 ANTI-CCR8 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF 住友ファーマ株式会社 2026-05-15 — — WO claimed
US-20260098072-A1 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO INC (US) 2026-04-09 — — US claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 — — EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 — — EP claimed
EP-4696699-A1 ? OPIOID RECEPTOR AGONIST AND USE THEREOF Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-18 — — EP claimed
EP-4696700-A1 LONG-ACTING K-OPIOID RECEPTOR AGONIST Chengdu Aoda Biotechnology Co., Ltd (CN) 2026-02-18 — — EP claimed
EP-4691482-A1 LONG-ACTING CALCITONIN ANALOG Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-11 — — EP claimed
EP-0533795-A1 COMPOSITION OF AND TREATMENT WITH BIOLOGICALLY ACTIVE PEPTIDES HAVING D-AMINO ACID RESIDUES MAGAININ PHARMACEUTICALS, INC. (US) 1993-03-31 — — EP claimed
WO-1991017760-A1 COMPOSITION OF AND TREATMENT WITH BIOLOGICALLY ACTIVE PEPTIDES HAVING D-AMINO ACID RESIDUES MAGAININ SCIENCES INC. (US) 1991-11-28 — — WO claimed
EP-0449973-A1 POLYPEPTIDE-POLYMER CONJUGATES ACTIVE IN WOUND HEALING. JOLLA CANCER RES FOUND (US) 1991-10-09 — — EP claimed
WO-1990006767-A1 POLYPEPTIDE-POLYMER CONJUGATES ACTIVE IN WOUND HEALING LA JOLLA CANCER RESEARCH FOUNDATION (US) 1990-06-28 — — WO claimed
US-4824660-A Method of determining the viability of tissue in an organism Angello, Paul S. (US) 1989-04-25 — — US claimed
US-4751299-A Optically active β-lactams and method of their production TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-06-14 — — US claimed
EP-0174979-A4 METHOD OF LOWERING BLOOD SUGAR LEVEL IN VERTEBRATES. ERK VERNON 1987-11-23 — — EP claimed
EP-0174979-A1 METHOD OF LOWERING BLOOD SUGAR LEVEL IN VERTEBRATES ERK, Vernon (US) 1986-03-26 — — EP claimed
WO-1985003872-A1 METHOD OF LOWERING BLOOD SUGAR LEVEL IN VERTEBRATES ERK VERNON 1985-09-12 — — WO claimed
US-4337247-A ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-06-29 — — US claimed
Send feedback